文献速递慢阻肺肺栓塞与肺血管病

慢性阻塞性肺疾病急性加重与心血管事件:SUMMIT随机临床试验的事后队列分析

Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01

本研究为SUMMIT试验的事后队列分析,纳入16,485例中度COPD且合并心血管疾病或高危因素的患者,比较AECOPD前后心血管事件风险。结果显示AECOPD后心血管事件风险显著增加,尤其在前30天(HR 3.8)和住院AECOPD后(HR 9.9),提示临床应加强AECOPD后早期心血管事件监测。

要点

  • AECOPD后心血管事件风险增加,前30天HR为3.8。
  • 住院AECOPD后30天心血管事件风险更高,HR达9.9。
  • AECOPD后1年内心血管风险持续升高。

核心结论

  • 在合并心血管疾病或高危因素的COPD患者中,AECOPD与后续心血管事件风险增加相关。
  • 住院AECOPD后及AECOPD后前30天风险最高。

研究设计与样本

  • SUMMIT随机临床试验的事后队列分析,纳入来自43个国家1,368个中心的16,485例中度COPD且合并心血管疾病或高危因素的患者。
  • AECOPD定义为呼吸道症状加重需抗生素、全身糖皮质激素和/或住院治疗。
  • 心血管事件为心血管死亡、心肌梗死、卒中、不稳定心绞痛和短暂性脑缺血发作的复合终点,均经裁定。

主要发现

  • 4,704例患者至少发生一次AECOPD,688例至少发生一次心血管事件。
  • AECOPD后心血管事件风险增加,前30天HR为3.8(95%CI 2.7-5.5)。
  • 住院AECOPD后30天HR为9.9(95%CI 6.6-14.9)。
  • AECOPD后1年内风险持续升高。

临床怎么用

  • 对COPD合并心血管疾病或高危因素的患者,AECOPD后应高度警惕早期心血管事件。
  • 住院AECOPD患者尤其需要加强心血管监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are common, associated with acute inflammation, and may increase subsequent cardiovascular disease (CVD) risk. OBJECTIVES: Determine whether AECOPD events are associated with increased risk of subsequent CVD. METHODS: We performed a secondary cohort analysis of the SUMMIT (Study to Understand Mortality and Morbidity) trial, a convenience sample of current/former smokers with moderate COPD from 1,368 centers in 43 countries. All had CVD or increased CVD risk. AECOPD was defined as an increase in respiratory symptoms requiring treatment with antibiotics, systemic corticosteroids, and/or hospitalization. CVD events were a composite outcome of cardiovascular death, myocardial infarction, stroke, unstable angina, and transient ischemic attack. All CVD events were adjudicated. Cox proportional hazards models compared the hazard for a CVD event before AECOPD versus after AECOPD. MEASUREMENTS AND MAIN RESULTS: Among 16,485 participants in SUMMIT, 4,704 participants had at least one AECOPD and 688 had at least one CVD event. The hazard ratio (HR) for CVD events after AECOPD was increased, particularly in the first 30 days after AECOPD (HR, 3.8; 95% confidence interval, 2.7-5.5) and was elevated up to 1 year after AECOPD. The 30-day HR after hospitalized AECOPD was more than twofold greater (HR, 9.9; 95% confidence interval, 6.6-14.9). CONCLUSIONS: In patients with COPD with CVD or risk factors for CVD, exacerbations confer an increased risk of subsequent CVD events, especially in hospitalized patients and within the first 30 days after exacerbation. Patients and clinicians should have heightened vigilance for early CVD events after AECOPD. Clinical trial registered with www.clinicaltrials.gov (NCT 01313676).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Kunisaki KM, Dransfield MT, Anderson JA, et al. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. Am J Respir Crit Care Med. 2018. PMID: 29442524. doi:10.1164/rccm.201711-2239OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。